SCHEMBL27384453

SCHEMBL27384453

Cc1cc2[nH]c(CNC(=O)N3CCC(C)C3)cc2cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ CYP2C9 P11712 3/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ RAB9A P51151 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ EPHX2 P34913 8/20 0.36
▸ USP2 O75604 1/20 0.36
▸ HPGD P15428 2/20 0.35
▸ CYP2J2 P51589 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ CHRNA7 P36544 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384649 0.85 HTT (0.42) SMN1; SMN2CYP2C9CYP1A2CYP3A4CYP2D6
SCHEMBL27384690 0.80 BTK (0.40) SMN1; SMN2CYP2C9CYP1A2CYP3A4CYP2D6
SCHEMBL27384661 0.78 EPHX2 (0.39) SMN1; SMN2CYP2C9CYP2C19RAB9AGRIN2B
SCHEMBL30920325 0.78 DGAT2 (0.34) SMN1; SMN2CYP2C9CYP1A2CYP3A4CYP2D6
SCHEMBL27385168 0.76 RAB9A (0.47) SMN1; SMN2CYP3A4CYP2D6RAB9AL3MBTL1
SCHEMBL27385697 0.74 SMN1; SMN2 (0.46) SMN1; SMN2CYP1A2RAB9AGRIN2BHPGD
SCHEMBL27384356 0.73 SMN1; SMN2 (0.40) SMN1; SMN2CYP2C9CYP2C19RAB9AGRIN2B
SCHEMBL27383346 0.73 RAB9A (0.45) SMN1; SMN2RAB9AGRIN2BMEN1LMNA
SCHEMBL27384652 0.73 SMN1; SMN2 (0.41) SMN1; SMN2CYP2C9CYP2C19RAB9AL3MBTL1
SCHEMBL27382975 0.73 CACNA1G (0.48) SMN1; SMN2CYP1A2RAB9AGRIN2BMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback